Trial Profile
A Phase 1, Open-label, Sequential Study to Investigate the Effect of JNJ 63623872 on Pitavastatin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Pimodivir (Primary) ; Pitavastatin
- Indications Influenza A virus infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 26 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 21 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.